137 "Accelerated Phase Chronic Myelogenous Leukemia" clinical trials found.

• 

  A Pilot Study of Diffusion Weighted MRI to Assess Esophageal Tumor Response to Neoadjuvant Chemoradiation

  The purpose of this study is to determine if a particular Magnetic Resonance Imaging (MRI) called Diffusion Weighted (dwMRI)) will ...

  Edgar Ben-Josef

• 

  Intratumoral Gene Mediated Cytotoxic Immunotherapy (GMCI) For Resectable Non-Small Cell Lung Cancer

  Surgery is the best treatment for patients with Stage I or II lung cancer; however, nearly 60% of patients have ...

  Sunil Singhal Md Charuhas Deshpande Lydia Frenzel Sulyok

• Study to Investigate Drug BIIB132 Administered to Adults With Spinocerebellar Ataxia 3

  The purpose of this research study is to learn more about a study drug that may affect patients with spinocerebellar ...

• UPCC 26921: A Phase 1a/1b Open-label Dose-Escalation and Expansion Study of TPST-1495 as a Single Agent and in Combination ...

  Please refer to Section 4 of the full protocol (Study Objectives and Endpoints) Please refer to Section 4 of the ...

  Thomas Karasic

• UPCC 04122 A Phase 1 Open-Label Multicenter Study of INCB123667 as Monotherapy in Participants With Selected Advanced Solid Tumors

  Please refer to Protocol Section 3 (Objectives and Endpoints). Please refer to Protocol Section 3 (Objectives and Endpoints). Please refer ...

• Study to Evaluate drug GS-8588 in People With HIV-1 Who are Virologically Suppressed on Antiretroviral Therapy

  The research study is being conducted to test an experimental drug, GS-8588, for the treatment and remission of human immunodeficiency ...

• Evaluating in vivo PARP-1 expression with 18F-FluorThanatrace positron emission tomography (PET/CT) in Patients with Pheochromocytoma and Paraganglioma

  The purpose of this study is to learn if a special type of imaging drug, called a “radioactive tracer” can ...

• UPCC 01622 Neoadjuvant PD-1 blockade in resectable Merkel cell carcinoma

  Please refer to Protocol Section 3.0 (Objective(s), Hypothesis(es), and Endpoint(s). Please refer to Protocol Section 3 ...

  John Miura

• UPCC 09922 A Phase 1 Open-label Multicenter Dose-ranging Study to Investigate Safety and Tolerability Efficacy Pharmacokinetics Pharmacodynamics and Immunogenicity of ...

  Please refer to Protocol Section 3 (Objectives and Endpoints). Please refer to Protocol Section 3 (Objectives and Endpoints). Please refer ...

  Melina Marmarelis

• A Phase 1/2a Open-Label Safety Pharmacokinetic and Preliminary Efficacy Trial of Oral ATRN-119 in Patients with Advanced Solid Tumors ...

  The study will evaluate the safety profile of escalating doses of continuous daily oral ATRN-119 and to determine the maximum ...

  Fiona Simpkins